Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04708769 · ClinicalTrials.gov registry record · NA

Elements Vital to Treat Obesity Study

A NA study of Obesity, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
524
Enrollment target
1
Study location

NCT04708769: Active NA study of Obesity, sponsored by Northwestern University.

NCT04708769 is a NA study of Obesity that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 524 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04708769, a NA study of Obesity, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
524 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP), to evaluate program weight-loss success and cost-effectiveness.

Primary Outcome

Participant change in weight, in kilograms, from baseline to 6-months.

Conditions Studied

Obesity

Interventions

  • BEHAVIORAL Smartphone App Participants (APP)
  • BEHAVIORAL Diabetes Prevention Program Participants (DPP)

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 524 participants
Start Date 2021-03-16
Est. Completion 2026-06-30
Phase NA
Northwestern University

1,209 total trials

What the registry record for NCT04708769 still lists

NCT04708769 is an interventional study that assigns participants to a tested intervention. The registered 524 participants enrollment target is mid-sized for trials with a published cap, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (36% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Smartphone App Participants (APP) is the first listed.

NCT04708769 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04708769 about?

NCT04708769 is a clinical study titled "Elements Vital to Treat Obesity Study". The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral...

What is the current status of trial NCT04708769?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 524 participants. The study started on 2021-03-16. Estimated completion is 2026-06-30.

What conditions does trial NCT04708769 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT04708769?

The interventions under investigation include: Smartphone App Participants (APP) (BEHAVIORAL), Diabetes Prevention Program Participants (DPP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04708769?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04708769 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04708769's enrollment target sits among peer trials

524 130th of 1053 higher than 924 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04580134 · 524 participants · Phase 4

    CLOZAPINE Response in Biotype-1

  • NCT07158814 · 524 participants · Phase 4

    Safety of RSV Preventive Monoclonal Antibody

  • NCT04769492 · 525 participants · NA

    #ChopViolence/#ChopHIV

  • NCT05260047 · 525 participants · NA

    Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04708769, the US trial registry maintained by the National Library of Medicine. NCT04708769 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.